Anticancer agent 129

• Description:

  Anticancer agent 129 (Compound 3a), a quinoline derivative, predicting to has anti-cancer activity[1].

• Product Name Alternative:

  UR-8880

• UNSPSC:

  12352005

• Target:

  Drug Derivative

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/anticancer-agent-129.html

• Purity:

  99.01

• Solubility:

  DMSO : 125 mg/mL (ultrasonic)

• Smiles:

  NC1=C2C(N(CC3=CC=CC=C3)CC2)=NC4=CC=CC=C14

• Molecular Formula:

  C18H17N3

• Molecular Weight:

  275.35

• References & Citations:

  [1]Vaidya A, et al. Predicting anti-cancer activity of quinoline derivatives: CoMFA and CoMSIA approach. J Enzyme Inhib Med Chem. 2011 Dec;26 (6) :854-61.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [135882-37-0]